Sign In
Buy KRYS
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?
04:40am, Saturday, 08'th Mar 2025
KRYS stock surges 15% in a month on strong uptake of Vyjuvek and encouraging pipeline progress. We are optimistic about the stock as we believe there is room for further growth.
Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?
04:35am, Saturday, 08'th Mar 2025
KRYS stock surges 15% in a month on strong uptake of Vyjuvek and encouraging pipeline progress. We are optimistic about the stock as we believe there is room for further growth.
KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug
12:01pm, Monday, 03'rd Mar 2025
Krystal Biotech receives positive CHMP opinion recommending the approval of Vyjuvek for treating dystrophic epidermolysis bullosa in the EU.
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
07:40am, Friday, 28'th Feb 2025
PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA's)
Why Krystal Biotech (KRYS) Might be Well Poised for a Surge
01:20pm, Monday, 24'th Feb 2025
Krystal Biotech (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Krystal Biotech, Inc. (KRYS) is a Top Momentum Stock for the Long-Term
10:55am, Monday, 24'th Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know
01:00pm, Friday, 21'st Feb 2025
Krystal Biotech (KRYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Krystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In Focus
08:15am, Friday, 21'st Feb 2025
Krystal Biotech's VYJUVEK shows strong growth, with 2025 sales expected to exceed $1B, bolstered by launches in the EU and Japan. Q4 earnings beat EPS expectations but slightly missed revenue forecast
Krystal Biotech Q4 Earnings Beat Estimates, Sales Miss, Stock Up
09:55am, Thursday, 20'th Feb 2025
KRYS stock gains despite reporting mixed fourth-quarter results as lead drug Vyjuvek's launch in the United States shows strong uptake.
Krystal Biotech, Inc. (KRYS) Q4 2024 Earnings Call Transcript
11:43am, Wednesday, 19'th Feb 2025
Krystal Biotech, Inc. (NASDAQ:KRYS ) Q4 2024 Results Conference Call February 19, 2025 8:30 AM ET Company Participants Stephane Paquette - VP, Corporate Development Krish Krishnan - Chairman and CEO J
Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results
07:00am, Wednesday, 19'th Feb 2025
Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023
Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock?
10:41am, Friday, 24'th Jan 2025
Investors need to pay close attention to Krystal Biotech (KRYS) stock based on the movements in the options market lately.
Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer
08:00am, Tuesday, 14'th Jan 2025
PITTSBURGH, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal's clinically va
Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy
08:30am, Friday, 27'th Dec 2024
Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales, doubling from Q4 2023. Trading at 57x 2024 earnings, Krystal's stock appears expensive but is projec
KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707
12:11pm, Thursday, 19'th Dec 2024
Krystal Biotech reports initial data from a phase I/II study showing therapeutic benefit in NSCLC patients treated with its immunotherapy candidate, KB707.
